Holen Sie sich die Stockscreener-App
0.401
5.50%
0.0209
Handel nachbörslich:
.42
0.019
+4.74%
Soligenix Inc Aktie (SNGX) Neueste Nachrichten
Soligenix (SNGX) Earnings Reading: The EPS Result Is Above Expectation in the Latest Session; Share Move - dars.gov.et
Soligenix (SNGX) Financial Results: The EPS Result Is Above Expectation in the Latest Reading; Latest Reaction: Shares Finish 3.79% Lower in the Available RecordRevenue Beat Analysis - vinanet.vn
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Provides Marginal BeatAnalyst Coverage Count - vinanet.vn
Soligenix Stock Price Forecast. Should You Buy SNGX? - StockInvest.us
SNGX Q1 2026 Earnings: Narrower Loss Offers Slight Beat, Yet No Revenue and Stock DipEarnings Trend Analysis - Vinanet
SNGX: Applying for Vaccine Development Funding for Ebola Vaccine - Smartkarma
Soligenix to Present at BIO Investment & Growth Summit (PR Newswire) - Aktiellt
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Share ReactionMid-Term Outlook - vinanet.vn
Soligenix culls topical lymphoma asset after Phase III miss - Yahoo Finance
Soligenix (SNGX) Receives a Buy from Alliance Global Partners - The Globe and Mail
A. G. P. Maintains Soligenix(SNGX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Soligenix Q2 net loss narrows as R&D expenses fall - TradingView
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - Barchart.com
SNGX Q1 2026 Earnings: Narrower Loss Provides Modest Upside SurpriseEarnings Beat Streak - vinanet.vn
Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Soligenix Inc. R (DOA0.MU) stock price, news, quote and history - Yahoo Finance UK
SOLIGENIX, INC. SEC Filing (Aug 3, 2026) - Stock Titan
SNGX Q1 2026 Earnings: Narrow Loss Beat Fails to Move SharesROE Trend Analysis - vinanet.vn
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss in a Revenue-Empty QuarterRevenue Growth Report - Vinanet
Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower Loss Per Share Signals Cost Management, but No Revenue ReportedMid-Term Outlook - dars.gov.et
Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Soligenix Inc (SNGX) Cash Flow - TradingKey
Soligenix Inc (SNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SNGX Stock Price, Quote & Chart - ChartMill
Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SNGX|Soligenix Inc|Price:0.374|Chg%:-0.001 - tradingkey.com
Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Soligenix Inc (SNGX) Institutional Confidence - TradingKey
Soligenix Inc (SNGX) Income Statement - TradingKey
SNGX|Soligenix Inc|Price:0.400|Chg%:+0.019 - TradingKey
Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX - TradingView
SNGX Q1 2026 Earnings: EPS Beat Driven by Cost Management Amid No RevenueProfit Margin Analysis - vinanet.vn
SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002 - TradingKey
Soligenix (SNGX) seeks reverse stock split and higher authorized shares - Stock Titan
Soligenix (SNGX) Q1 2026 Earnings: Narrower-than-expected net loss per share amid steady pipeline advancement - dars.gov.et
SNGX News | SOLIGENIX INC (NASDAQ:SNGX) - ChartMill
Soligenix (SNGX) seeks reverse stock split, higher share authorization to protect Nasdaq listing - Stock Titan
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances Pipeline with No RevenueRetail Earnings Report - vinanet.vn
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline ProgressEstimate Uncertainty - dars.gov.et
Soligenix (SNGX) Edges Higher Amid Key Resistance TestMomentum Breakout Ideas - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Development ContinuesAnnual Earnings Summary - dars.gov.et
Soligenix Q1 2026 Earnings: Narrower-than-Expected Loss Reflects Cost ManagementAnalyst Drop Coverage - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Small EPS Beat Amid Continued Pipeline ProgressEstimate Dispersion - dars.gov.et
Soligenix, Inc. Financial Disclosures & SEC Filings - TradingView
Soligenix Expands At-the-Market Equity Offering Capacity - The Globe and Mail
SNGX Stock Slumps To Record Low After Lymphoma Trial Fails – All Eyes Now On Behçet’s Disease Treatment - Stocktwits
Form 424B5 Soligenix Inc For: 26 June - Investing.com UK
Form 424B5 Soligenix Inc For: 26 June By Investing.com - Investing.com Nigeria
Soligenix ups ATM offering by $2.5M under Rodman & Renshaw agreement - TradingView
Soligenix (NASDAQ: SNGX) adds $2.5M to at-the-market stock program - Stock Titan
Soligenix (NASDAQ: SNGX) resets ATM capacity to $2.5M under S-3 - Stock Titan
Michael Liu, MJL Manager (SNGX) disclose 983,588 shares; related group holds material blocks - Stock Titan
Soligenix, Inc. Actuals & Estimates (NASDAQ:SNGX) - TradingView
SNGX Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
Price to earnings forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - Stocktwits
Soligenix (SNGX) Slips 2.31% as Stock Nears Key Support at $0.36Ichimoku Entry - po-news-eg.net
1.21%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):